Studies of the health effects of a daily physical activity programme have been carried out in 10-year-old school children in Adelaide, South Australia. In the first phase (1978) observations on endurance fitness, four skin folds, blood pressure and blood lipids were made before and after a randomized trial over a period of 14 weeks. Comparisons were made on over 500 children drawn from classes in seven Primary schools involved in an endurance fitness programme (1 1/4 hours per day), a skill programme and the previous physical education programme (controls). The fitness group experienced significant gains in physical work capacity (PWC) and showed significant decreases in body fat compared to the other two groups. No significant differences were observed in plasma cholesterol, triglycerides and HDL cholesterol. Subsequently in the second phase (1980) observations were made on a group of 216 10-year-old children who had already experienced two years of the physical activity programme adopted after phase one. Comparison with the observations in the 10-year-old children in 1978 made prior to the intervention revealed significantly smaller skin folds and greater PWC, with lower blood pressure reaching statistical significance for diastolic pressure in boys. The findings suggest beneficial effects on health of daily physical activity programmes within existing primary school curricula. There was no evidence of any loss of academic performance as measured by arithmetic and reading tests in spite of 45-60 minutes' loss of formal teaching time each day.

Patients with a second or subsequent primary cancer of a single type represent a potentially valuable and under-utilized resource for the study of cancer aetiology.

No abstract

This study provided Class III evidence that IFN-β is associated with reduced risk of relapse, and this effect may be modified by a positive effect of IFN-β on serum 25(OH)D levels.

Background: Although elevated blood pressure is associated with an increased risk of atrial fibrillation (AF), it is unclear if this association varies by individual characteristics. Furthermore, the associations between AF and a range of different vascular events are yet to be reliably quantified. Methods: Using linked electronic health records, we examined the time to first diagnosis of AF and time to first diagnosis of nine vascular events in a cohort of 4.3 million adults, aged 30 to 90 years, in the UK. Results: A 20-mmHg higher usual systolic blood pressure was associated with a higher risk of AF [hazard ratio (HR) 1.21, 95% confidence interval (CI) 1.19, 1.22]. The strength of the association declined with increasing age, from an HR of 1.91 (CI 1.75, 2.09) at age 30-40 to an HR of 1.01 (CI 0.97, 1.04) at age 80-90 years. AF without antithrombotic use at baseline was associated with a greater risk of any vascular event than AF with antithrombotic usage (P interaction < 0.0001). AF without baseline antithrombotic usage was associated with an increased risk of ischaemic heart disease (HR 2.52, CI 2.23, 2.84), heart failure (HR 3.80, CI 3.50, 4.12), ischaemic stroke (HR 2.72, CI 2.19, 3.38), unspecified stroke (HR 2.59, CI 2.25, 2.99), haemorrhagic stroke, chronic kidney disease, peripheral arterial disease and vascular dementia, but not aortic aneurysm. Conclusions: The association between elevated blood pressure and AF attenuates with increasing age. AF without antithrombotic usage is associated with an increased risk of eight vascular events.